PIRAMAL PHARMA LIMITED Valuation
PPLPHARMA · Healthcare · Current price ₹213.03
Is PIRAMAL PHARMA LIMITED undervalued?
DocStoX does not publish a single fair-value estimate for PIRAMAL PHARMA LIMITED. Loss-making — an earnings-based fair value does not apply to a company with no positive earnings. We would rather show no number than a misleading one.
How this fair value is calculated
No individual valuation method had enough clean data to run for this company.
Bear, base and bull scenarios
Scenario analysis is unavailable without a base fair value.
Valuation multiples
PIRAMAL PHARMA LIMITED trades at a P/E of 31.9x and a P/B of 3.5x, with a dividend yield of 0.1%. Multiples are most useful compared against the company's own history and its sector peers — see the peer comparison for context.
Understand the ratios
More on PIRAMAL PHARMA LIMITED
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.